Page last updated: 2024-12-11

cytochalasin e

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cytochalasin E: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5458385
CHEMBL ID494856
CHEBI ID68201
SCHEMBL ID33617
MeSH IDM0050264

Synonyms (23)

Synonym
36011-19-5
cytochalasin e
21,19-diene-1,17,22-trione, 6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-, (7s,13e,16s,18r,19e)-
nsc-175151
NSC175151 ,
hsdb 3548
21,23-dioxa(13)cytochalasa-13,19-diene-1,17,22-trione, 6,7-epoxy-18-hydroxy-16,18-dimethyl-10-phenyl-, (7s,13e,16s,18r,19e)-
einecs 252-835-7
nsc 175151
6,7-epoxy-10-phenyl-5,6,16,18-tetramethyl-21,23-dioxa-(13)cytochalas-13,19-diene-17,22-dione
cytochalasin e from aspergillus clavatus
cytochalasin e, aspergillus clavatus
CHEMBL494856
chebi:68201 ,
CCG-39859
SCHEMBL33617
mfcd00005178
NCGC00380287-01
DTXSID60894866
Q5201338
HY-N6772
CS-0093424
AKOS040741587

Research Excerpts

Overview

Cytochalasin E was found to be a potent and selective inhibitor of bovine capillary endothelial (BCE) cell proliferation. It decreased both these transports only when used at very high concentrations.

ExcerptReferenceRelevance
"Cytochalasin E was found to be a potent and selective inhibitor of bovine capillary endothelial (BCE) cell proliferation."( Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
Chang, YH; D'Amato, RJ; Panigrahy, D; Shah, J; Udagawa, T; Yuan, J, 2000
)
2.47
"The cytochalasin E, claimed to be a nonspecific inhibitor, decreased both these transports only when used at very high concentrations, as described for sugar influx in the same structure."( Reversible in vitro decrease of L-tyrosine and L-tryptophan influx across the human erythrocyte membrane induced by cytochalasin B, the specific inhibitor of D-glucose transport.
Bovier, P; Gaillard, JM; Raffin, Y; Tissot, R; Widmer, J,
)
0.61

Actions

ExcerptReferenceRelevance
"Cytochalasin E does not inhibit this carrier function."( Cytochalasin B binding to Ehrlich ascites tumor cells and its relationship to glucose carrier.
Cuppoletti, J; Jung, CY; Mayhew, E, 1981
)
0.98

Treatment

ExcerptReferenceRelevance
"Cytochalasin E treatment disrupted the association between ENaC and myristoylated alanine-rich C-kinase substrate."( Cytochalasin E alters the cytoskeleton and decreases ENaC activity in Xenopus 2F3 cells.
Alli, AA; Bao, HF; Duke, BJ; Eaton, DC; Liu, BC; Ma, HP; Reifenberger, MS; Yu, L, 2014
)
2.57

Toxicity

ExcerptReferenceRelevance
" The adult LD50 for CD (1."( Differences in the toxicity and teratogenicity of cytochalasins D and E in various mouse strains.
Austin, WL; Brown, KS; Wind, M, 1982
)
0.26

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" The dose-response effect for the two different cytochalasins differed in accordance with the different cell specificity of their membrane binding."( Kinetic and morphological changes induced in human blood leucocytes by cytochalasin D and E.
Boll, I; Lichter, JH, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cytochalasan alkaloidAny alkaloid characterized by the presence of an isoindole nucleus fused to a macrocyclic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID611590Antiangiogenesis activity in HUAEC assessed as inhibition of VEGF-induced cell proliferation after 72 hrs by MTT assay2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Chemical constituents of a marine fungus, Arthrinium sacchari.
AID377008Cytotoxicity against human A549 cells after 72 hrs by MTT method2006Journal of natural products, Jun, Volume: 69, Issue:6
10-Phenyl-[12]-cytochalasins Z7, Z8, and Z9 from the marine-derived fungus Spicaria elegans.
AID611589Antiangiogenesis activity in HUVEC assessed as inhibition of VEGF-induced cell proliferation after 72 hrs by MTT assay2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Chemical constituents of a marine fungus, Arthrinium sacchari.
AID680702TP_TRANSPORTER: increase in Vinblastine intracellular accumulation (Vinblastine: 0.01-0.02 uM, Cytochalasine E: 10 uM) in MCF-7/ADR cells1995Oncology research, , Volume: 7, Issue:9
Differential interactions of cytochalasins with P-glycoprotein.
AID378646Cytotoxicity against human HCT116 cells after 72 hrs2000Journal of natural products, Dec, Volume: 63, Issue:12
Three new cytochalasins produced by an endophytic fungus in the genus Rhinocladiella.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID378647Cytotoxicity against human A2780S cells after 72 hrs2000Journal of natural products, Dec, Volume: 63, Issue:12
Three new cytochalasins produced by an endophytic fungus in the genus Rhinocladiella.
AID378645Cytotoxicity against human SW620 cells after 72 hrs2000Journal of natural products, Dec, Volume: 63, Issue:12
Three new cytochalasins produced by an endophytic fungus in the genus Rhinocladiella.
AID377007Cytotoxicity against mouse P388 cells after 72 hrs by MTT method2006Journal of natural products, Jun, Volume: 69, Issue:6
10-Phenyl-[12]-cytochalasins Z7, Z8, and Z9 from the marine-derived fungus Spicaria elegans.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (129)

TimeframeStudies, This Drug (%)All Drugs %
pre-199049 (37.98)18.7374
1990's35 (27.13)18.2507
2000's22 (17.05)29.6817
2010's21 (16.28)24.3611
2020's2 (1.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.24 (24.57)
Research Supply Index4.88 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other129 (99.23%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]